Where's the Bias?

Frank Davidoff

doi:10.7326/0003-4819-126-12-199706150-00011

Editorials |15 June 1997

Where's the Bias?

Frank Davidoff, MD, Editor

Article, Author, and Disclosure Information

In July 1996, Annals published the results of a double-blind, randomized, controlled trial describing the effects of zinc lozenges on the symptoms of the common cold [1]. The lozenges, produced by the Quigley Corporation of Doylestown, Pennsylvania, seemed to reduce the duration of symptoms by about 40% compared with placebo, confirming the results of several previous studies but contrasting with the findings of others. As noted in the published article, the study was supported by funds from the researchers' institution; the Quigley Corporation supplied the active medication and the placebo.

In the cover letter that accompanied the manuscript, the authors told us that none of them had held any financial interest in Quigley before designing and conducting the study but that after the randomization code was broken and the results analyzed two of the authors, Dr. Macknin and Ms. Medendorp, had acquired stock in Quigley through private sale. Annals was therefore duly informed about a potential conflict of interest. In our judgment, the potential for bias from commercial influence was minimal because the financial link between the authors and the company occurred after the fact of the research; we therefore chose not to publish the authors' disclosure.

FULL TEXT

PDF

Not Available

Editorials |15 June 1997

Where's the Bias?

Related Articles

Journal Club

Related Topics

PubMed Articles

Content

Information For

Services

Awards and Cover

Other Resources

Follow Annals On

Editorials |15 June 1997

Where's the Bias?

Related Articles

Journal Club

Related Topics

PubMed Articles

Content

Information For

Services

Awards and Cover

Other Resources

Follow Annals On

You need a subscription to this content to use this feature.